The directors are selling (using the usual tired 'paying taxes' excuse) . But the retail punters are still deluded enough to believe CUV has a pipeline of wonder drugs about to hit the market (despite 50 years of failed clinical trials of MSH analogues). Total cognitive dissonance.
CUV Price at posting:
$16.38 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)